ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Spinal and Bulbar Muscular Atrophy Treatment Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-24H7799
Home | Market Reports | Health| Health Conditions| Neurological Conditions
Global Spinal and Bulbar Muscular Atrophy Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Spinal and Bulbar Muscular Atrophy Treatment Market Research Report 2025

Code: QYRE-Auto-24H7799
Report
July 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Pfizer Inc
GlaxoSmithKline PLC
Johnson & Johnson
Century Pharmaceuticals
Astellas Pharma
Sanofi
Boehringer Ingelheim International

Spinal and Bulbar Muscular Atrophy Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Spinal and Bulbar Muscular Atrophy Treatment Market

Spinal and Bulbar Muscular Atrophy Treatment Market

The global market for Spinal and Bulbar Muscular Atrophy Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
SBMA, mainly manifested as systemic muscle atrophy, paralysis and systemic muscle bundle tremor, patients with systemic muscle weakness, especially the weakness of the two lower limbs to walk, tongue muscle atrophy is usually one of the main symptoms.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Spinal and Bulbar Muscular Atrophy Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spinal and Bulbar Muscular Atrophy Treatment.
The Spinal and Bulbar Muscular Atrophy Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Spinal and Bulbar Muscular Atrophy Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Spinal and Bulbar Muscular Atrophy Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Spinal and Bulbar Muscular Atrophy Treatment Market Report

Report Metric Details
Report Name Spinal and Bulbar Muscular Atrophy Treatment Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie, Pfizer, GlaxoSmithKline, Johnson & Johnson, Century Pharmaceuticals, Astellas Pharma, Sanofi, Boehringer Ingelheim International
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Spinal and Bulbar Muscular Atrophy Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Spinal and Bulbar Muscular Atrophy Treatment Market report?

Ans: The main players in the Spinal and Bulbar Muscular Atrophy Treatment Market are AbbVie, Pfizer, GlaxoSmithKline, Johnson & Johnson, Century Pharmaceuticals, Astellas Pharma, Sanofi, Boehringer Ingelheim International

What are the Application segmentation covered in the Spinal and Bulbar Muscular Atrophy Treatment Market report?

Ans: The Applications covered in the Spinal and Bulbar Muscular Atrophy Treatment Market report are Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers

What are the Type segmentation covered in the Spinal and Bulbar Muscular Atrophy Treatment Market report?

Ans: The Types covered in the Spinal and Bulbar Muscular Atrophy Treatment Market report are 5α-Reductase Inhibitors, Gonadotropin-releasing Hormone Agonists

Recommended Reports

Neuromuscular Disease Treatments

Neurodegenerative Therapies

Musculoskeletal & Spine Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 5α-Reductase Inhibitors
1.2.3 Gonadotropin-releasing Hormone Agonists
1.3 Market by Application
1.3.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Orthopedic Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Perspective (2020-2031)
2.2 Global Spinal and Bulbar Muscular Atrophy Treatment Growth Trends by Region
2.2.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Spinal and Bulbar Muscular Atrophy Treatment Historic Market Size by Region (2020-2025)
2.2.3 Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Region (2026-2031)
2.3 Spinal and Bulbar Muscular Atrophy Treatment Market Dynamics
2.3.1 Spinal and Bulbar Muscular Atrophy Treatment Industry Trends
2.3.2 Spinal and Bulbar Muscular Atrophy Treatment Market Drivers
2.3.3 Spinal and Bulbar Muscular Atrophy Treatment Market Challenges
2.3.4 Spinal and Bulbar Muscular Atrophy Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Revenue
3.1.1 Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Revenue (2020-2025)
3.1.2 Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Spinal and Bulbar Muscular Atrophy Treatment Revenue
3.4 Global Spinal and Bulbar Muscular Atrophy Treatment Market Concentration Ratio
3.4.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spinal and Bulbar Muscular Atrophy Treatment Revenue in 2024
3.5 Global Key Players of Spinal and Bulbar Muscular Atrophy Treatment Head office and Area Served
3.6 Global Key Players of Spinal and Bulbar Muscular Atrophy Treatment, Product and Application
3.7 Global Key Players of Spinal and Bulbar Muscular Atrophy Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Spinal and Bulbar Muscular Atrophy Treatment Breakdown Data by Type
4.1 Global Spinal and Bulbar Muscular Atrophy Treatment Historic Market Size by Type (2020-2025)
4.2 Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Type (2026-2031)
5 Spinal and Bulbar Muscular Atrophy Treatment Breakdown Data by Application
5.1 Global Spinal and Bulbar Muscular Atrophy Treatment Historic Market Size by Application (2020-2025)
5.2 Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size (2020-2031)
6.2 North America Spinal and Bulbar Muscular Atrophy Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2020-2025)
6.4 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size (2020-2031)
7.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2020-2025)
7.4 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size (2020-2031)
8.2 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size (2020-2031)
9.2 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2020-2025)
9.4 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size (2020-2031)
10.2 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.1.4 AbbVie Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025)
11.1.5 AbbVie Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.2.4 Pfizer Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025)
11.3.5 GlaxoSmithKline Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025)
11.4.5 Johnson & Johnson Recent Development
11.5 Century Pharmaceuticals
11.5.1 Century Pharmaceuticals Company Details
11.5.2 Century Pharmaceuticals Business Overview
11.5.3 Century Pharmaceuticals Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.5.4 Century Pharmaceuticals Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025)
11.5.5 Century Pharmaceuticals Recent Development
11.6 Astellas Pharma
11.6.1 Astellas Pharma Company Details
11.6.2 Astellas Pharma Business Overview
11.6.3 Astellas Pharma Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.6.4 Astellas Pharma Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025)
11.6.5 Astellas Pharma Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.7.4 Sanofi Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025)
11.7.5 Sanofi Recent Development
11.8 Boehringer Ingelheim International
11.8.1 Boehringer Ingelheim International Company Details
11.8.2 Boehringer Ingelheim International Business Overview
11.8.3 Boehringer Ingelheim International Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.8.4 Boehringer Ingelheim International Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025)
11.8.5 Boehringer Ingelheim International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
AbbVie
Pfizer Inc
GlaxoSmithKline PLC
Johnson & Johnson
Century Pharmaceuticals
Astellas Pharma
Sanofi
Boehringer Ingelheim International
List of Tables
 Table 1. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of 5α-Reductase Inhibitors
 Table 3. Key Players of Gonadotropin-releasing Hormone Agonists
 Table 4. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Region (2020-2025)
 Table 8. Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Region (2026-2031)
 Table 10. Spinal and Bulbar Muscular Atrophy Treatment Market Trends
 Table 11. Spinal and Bulbar Muscular Atrophy Treatment Market Drivers
 Table 12. Spinal and Bulbar Muscular Atrophy Treatment Market Challenges
 Table 13. Spinal and Bulbar Muscular Atrophy Treatment Market Restraints
 Table 14. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Players (2020-2025)
 Table 16. Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal and Bulbar Muscular Atrophy Treatment as of 2024)
 Table 17. Ranking of Global Top Spinal and Bulbar Muscular Atrophy Treatment Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Spinal and Bulbar Muscular Atrophy Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Spinal and Bulbar Muscular Atrophy Treatment, Headquarters and Area Served
 Table 20. Global Key Players of Spinal and Bulbar Muscular Atrophy Treatment, Product and Application
 Table 21. Global Key Players of Spinal and Bulbar Muscular Atrophy Treatment, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Type (2020-2025)
 Table 25. Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Type (2026-2031)
 Table 27. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Application (2020-2025)
 Table 29. Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Application (2026-2031)
 Table 31. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 46. AbbVie Company Details
 Table 47. AbbVie Business Overview
 Table 48. AbbVie Spinal and Bulbar Muscular Atrophy Treatment Product
 Table 49. AbbVie Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025) & (US$ Million)
 Table 50. AbbVie Recent Development
 Table 51. Pfizer Company Details
 Table 52. Pfizer Business Overview
 Table 53. Pfizer Spinal and Bulbar Muscular Atrophy Treatment Product
 Table 54. Pfizer Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025) & (US$ Million)
 Table 55. Pfizer Recent Development
 Table 56. GlaxoSmithKline Company Details
 Table 57. GlaxoSmithKline Business Overview
 Table 58. GlaxoSmithKline Spinal and Bulbar Muscular Atrophy Treatment Product
 Table 59. GlaxoSmithKline Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025) & (US$ Million)
 Table 60. GlaxoSmithKline Recent Development
 Table 61. Johnson & Johnson Company Details
 Table 62. Johnson & Johnson Business Overview
 Table 63. Johnson & Johnson Spinal and Bulbar Muscular Atrophy Treatment Product
 Table 64. Johnson & Johnson Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025) & (US$ Million)
 Table 65. Johnson & Johnson Recent Development
 Table 66. Century Pharmaceuticals Company Details
 Table 67. Century Pharmaceuticals Business Overview
 Table 68. Century Pharmaceuticals Spinal and Bulbar Muscular Atrophy Treatment Product
 Table 69. Century Pharmaceuticals Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025) & (US$ Million)
 Table 70. Century Pharmaceuticals Recent Development
 Table 71. Astellas Pharma Company Details
 Table 72. Astellas Pharma Business Overview
 Table 73. Astellas Pharma Spinal and Bulbar Muscular Atrophy Treatment Product
 Table 74. Astellas Pharma Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025) & (US$ Million)
 Table 75. Astellas Pharma Recent Development
 Table 76. Sanofi Company Details
 Table 77. Sanofi Business Overview
 Table 78. Sanofi Spinal and Bulbar Muscular Atrophy Treatment Product
 Table 79. Sanofi Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025) & (US$ Million)
 Table 80. Sanofi Recent Development
 Table 81. Boehringer Ingelheim International Company Details
 Table 82. Boehringer Ingelheim International Business Overview
 Table 83. Boehringer Ingelheim International Spinal and Bulbar Muscular Atrophy Treatment Product
 Table 84. Boehringer Ingelheim International Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025) & (US$ Million)
 Table 85. Boehringer Ingelheim International Recent Development
 Table 86. Research Programs/Design for This Report
 Table 87. Key Data Information from Secondary Sources
 Table 88. Key Data Information from Primary Sources
 Table 89. Authors List of This Report


List of Figures
 Figure 1. Spinal and Bulbar Muscular Atrophy Treatment Picture
 Figure 2. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type: 2024 VS 2031
 Figure 4. 5α-Reductase Inhibitors Features
 Figure 5. Gonadotropin-releasing Hormone Agonists Features
 Figure 6. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals Case Studies
 Figure 9. Orthopedic Clinics Case Studies
 Figure 10. Ambulatory Surgical Centers Case Studies
 Figure 11. Spinal and Bulbar Muscular Atrophy Treatment Report Years Considered
 Figure 12. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Region: 2024 VS 2031
 Figure 15. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Players in 2024
 Figure 16. Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal and Bulbar Muscular Atrophy Treatment as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Spinal and Bulbar Muscular Atrophy Treatment Revenue in 2024
 Figure 18. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2020-2031)
 Figure 20. United States Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2020-2031)
 Figure 24. Germany Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Share by Region (2020-2031)
 Figure 32. China Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2020-2031)
 Figure 40. Mexico Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2020-2031)
 Figure 44. Turkey Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. AbbVie Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025)
 Figure 48. Pfizer Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025)
 Figure 49. GlaxoSmithKline Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025)
 Figure 50. Johnson & Johnson Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025)
 Figure 51. Century Pharmaceuticals Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025)
 Figure 52. Astellas Pharma Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025)
 Figure 53. Sanofi Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025)
 Figure 54. Boehringer Ingelheim International Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2020-2025)
 Figure 55. Bottom-up and Top-down Approaches for This Report
 Figure 56. Data Triangulation
 Figure 57. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Spinal Muscular Atrophy SMA Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bulbospinal Muscular Atrophy Drugs Market Research Report 2024
Spinal Muscular Atrophy SMA Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Spinal Muscular Atrophy Medicine Market Research Report 2025
Global Spinal Muscular Atrophy SMA Treatment Market Research Report 2024
Spinal Muscular Atrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Myotonic Muscular Dystrophy DMD Treatments Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Multiple System Atrophy Therapeutics Market Research Report 2024
Global Drugs for Spinal Muscular Atrophy SMA Market Research Report 2024
Systemic Scleroderma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Handheld Neuromuscular Electrical Stimulator Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Injections for SMA Market Research Report 2024
Neurodegenerative Diseases Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neurodegenerative Disease Treatment Market Research Report 2024
Duchenne Muscular Dystrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Spinal Cord Stimulator Market Research Report 2025
Global Progressive Supranuclear Palsy Market Research Report 2024
Myotubular Myopathy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Becker Muscular Dystropy Market Research Report 2025
Global Amyotrophic Lateral Sclerosis Device Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions